OG, et al
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.
Clin Cancer Res
©2019 American Association for Cancer Research.
American Association for Cancer Research.